Skip to Content
77 Mass Ave

Experimental molecules fight covid

Researchers are testing lab-designed peptides and cytokine receptors.
June 16, 2020

Two MIT research groups have designed biological molecules that could help combat the effects of covid-19.

One team, led by principal research scientist Shuguang Zhang and research scientist Rui Qing, developed proteins that could be injected into the body to block “cytokine storms,” immune-system overreactions that damage the lungs and can be fatal. The proteins, lab-modified versions of naturally occurring cytokine receptors, could bind to excess cytokines and remove them from the system, says Qing. Tests in human cells and animal models are planned.

The other team, led by associate professor of chemistry Brad Pentelute, designed a short protein fragment, or peptide, that can bind to the viral protein used to enter human lung cells, potentially disarming it. The peptide mimics a cell surface protein that attaches to one of the protein spikes protruding from the coronavirus. The researchers have sent samples to collaborators who plan to carry out tests in human cells. 

Keep Reading

Most Popular

Geoffrey Hinton tells us why he’s now scared of the tech he helped build

“I have suddenly switched my views on whether these things are going to be more intelligent than us.”

ChatGPT is going to change education, not destroy it

The narrative around cheating students doesn’t tell the whole story. Meet the teachers who think generative AI could actually make learning better.

Meet the people who use Notion to plan their whole lives

The workplace tool’s appeal extends far beyond organizing work projects. Many users find it’s just as useful for managing their free time.

Learning to code isn’t enough

Historically, learn-to-code efforts have provided opportunities for the few, but new efforts are aiming to be inclusive.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.